Pang‐Dian Fan

Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring <i>MET</i> Mutations Causing Exon 14 Skipping

Paul K. Paik, Alexander Drilon, Pang‐Dian Fan et al. · Cancer Discovery · 2015 · 571 citations · Full text

Medicine, Oncology, Pharmacology +15

Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors

Katerina Politi, Maureen F. Zakowski, Pang‐Dian Fan et al. · Genes & Development · 2006 · 486 citations · Full text

Medicine, Oncology, Pharmacology +17

HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy

Helena A. Yu, Yasushi Goto, Hidetoshi Hayashi et al. · Journal of Clinical Oncology · 2023 · 225 citations · Full text

Medicine, Oncology, Pharmacology +14

The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts.

R Misra, Victor M. Rivera, J M Wang et al. · Molecular and Cellular Biology · 1991 · 92 citations

Life Sciences, Biochemistry, Cell Biology +11

Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma

Katerina Politi, Pang‐Dian Fan, Ronglai Shen et al. · Disease Models & Mechanisms · 2009 · 90 citations · Full text

Medicine, Oncology, Pharmacology +17